Supernus Pharmaceuticals (SUPN) P/B (2012 - 2026)
Supernus Pharmaceuticals (SUPN) P/B from May 1, 2012 to Jul 21, 2026. The TTM Supernus Pharmaceuticals (SUPN) P/B is 2.58. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Supernus Pharmaceuticals (SUPN)
| Year | P/B | Change |
|---|---|---|
| 2026 | 2.58 | -4.07% |
| 2025 | 2.69 | +38.21% |
| 2024 | 1.95 | +13.07% |
| 2023 | 1.72 | -22.73% |
| 2022 | 2.23 | +17.03% |
| 2021 | 1.90 | +6.59% |
| 2020 | 1.79 | -14.67% |
| 2019 | 2.09 | -45.45% |
| 2018 | 3.84 | -52.74% |
| 2017 | 8.12 | +12.51% |
| 2016 | 7.22 | +30.23% |
| 2015 | 5.54 | +10.82% |
| 2014 | 5.00 | -27.55% |
| 2013 | 6.90 | +80.93% |
| 2012 | 3.81 | N/A |
Comparison Supernus Pharmaceuticals (SUPN) P/B with competitors
Supernus Pharmaceuticals (SUPN) P/B is 2.58.